source
- Experts warn of safety risks as FDA targets compounded GLP-1 weight-loss drugs sold by telehealth firmsAt the HLTH conference, experts highlighted growing concerns about telehealth companies that sell compounded GLP-1 weight-loss medications. These firms create custom formulations and ship them dir…
- Quanterix CEO Everett Cunningham resigns after ten months, interim leader appointedQuanterix announced that Everett Cunningham will leave his role as president and chief executive officer after serving less than a year. The company said he will step down to pursue another opportu…